cenegermin-bkbj

FDA Drug Profile — OXERVATE

Drug Details

Generic Name
cenegermin-bkbj
Brand Names
OXERVATE
Application Number
BLA761094
Sponsor
Domp farmaceutici S.p.A.
NDC Codes
2
Dosage Forms
SOLUTION/ DROPS, KIT
Routes
OPHTHALMIC
Active Ingredients
CENEGERMIN

Indications and Usage

1 INDICATIONS AND USAGE OXERVATE ® (cenegermin-bkbj) ophthalmic solution 0.002% is indicated for the treatment of neurotrophic keratitis. OXERVATE is a recombinant human nerve growth factor indicated for the treatment of neurotrophic keratitis. ( 1 )